Anemia Drug Market to Reach USD 15.6 Billion by 2032 Growing at 8.4% CAGR Driven by Rising Global Anemia Prevalence
The global Anemia Drug market is witnessing significant growth due to increasing prevalence of iron-deficiency anemia, chronic kidney disease, and other hematological disorders. In 2023 , the market was valued at USD 8.2 billion , rising from USD 7.6 billion in 2022 , reflecting a 7.9% year-over-year growth rate . Rising geriatric population, dietary deficiencies, and growing...
0 ความคิดเห็น 0 แชร์ 357 ยอดวิว 0 รีวิว